中国卒中杂志2016，Vol.11Issue(12)：1067-1071,5.DOI:10.3969/j.issn.1673-5765.2016.12.014
糖化血红蛋白在缺血性卒中应用研究进展
Application Research Progress about Glycosylated Hemoglobin A1c in Patients with Ischemic Stroke
摘要
Abstract
Glycosylated hemoglobin A1c (HbA1c) is an accurate and stable parameter that relfects glycemic level in human body of certain time. It participates in the progress of ischemic stroke and inlfuences the prognosis of patients. So HbA1c could be taken as a routine monitoring index for ischemic stroke and to guide the treatment and prognosis. This article will introduce the present situation of the HbA1c in the development, diagnosis, treatment and prognosis of the patients with ischemic stroke.关键词
糖化血红蛋白/缺血性卒中/机制/预后Key words
Glycosylated hemoglobin A1c/Ischemic stroke/Mechanism/Prognosis引用本文复制引用
刘丽丽,李国忠,钟镝,陈洪苹..糖化血红蛋白在缺血性卒中应用研究进展[J].中国卒中杂志,2016,11(12):1067-1071,5.基金项目
国家卫生计生委重点临床专科建设项目，省攻关重大项目子课题（GA14C101-04）博士学科点专项科研基金联合资助课题 （）
